Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease

BACKGROUND: Methylxanthines and leukotriene receptor antagonists (LTRA) are not a first-line medical treatment for chronic obstructive pulmonary disease (COPD) but are frequently prescribed despite limited evidence. We aimed to elucidate the real prescribing status and clinical impacts of these agen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Lee, Jung-Kyu, Rhee, Chin Kook, Kim, Kyungjoo, Ra, Seung Won, Lee, Jae Ha, Jung, Ki-Suck, Yoo, Kwang Ha, Kim, Yoo-Il, Kim, Deog Kyeom
Format: Artigo
Idioma:Inglês
Publicat: Dove 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885559/
https://ncbi.nlm.nih.gov/pubmed/31819397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S216326
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars